YU39914B - Process for obtaining 1-(3-(4-m-chlorophenyl-1-piperazinyl)-propyl)3,4-diethyl-delta2-1,24-triazoline-5-one - Google Patents

Process for obtaining 1-(3-(4-m-chlorophenyl-1-piperazinyl)-propyl)3,4-diethyl-delta2-1,24-triazoline-5-one

Info

Publication number
YU39914B
YU39914B YU2634/73A YU263473A YU39914B YU 39914 B YU39914 B YU 39914B YU 2634/73 A YU2634/73 A YU 2634/73A YU 263473 A YU263473 A YU 263473A YU 39914 B YU39914 B YU 39914B
Authority
YU
Yugoslavia
Prior art keywords
delta2
triazoline
piperazinyl
chlorophenyl
diethyl
Prior art date
Application number
YU2634/73A
Other languages
English (en)
Other versions
YU263473A (en
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of YU263473A publication Critical patent/YU263473A/xx
Publication of YU39914B publication Critical patent/YU39914B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
YU2634/73A 1972-10-16 1973-10-08 Process for obtaining 1-(3-(4-m-chlorophenyl-1-piperazinyl)-propyl)3,4-diethyl-delta2-1,24-triazoline-5-one YU39914B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT53380/72A IT1052119B (it) 1972-10-16 1972-10-16 Derivati del triazolinone e procedimento per la loro preparazione

Publications (2)

Publication Number Publication Date
YU263473A YU263473A (en) 1983-02-28
YU39914B true YU39914B (en) 1985-06-30

Family

ID=11282276

Family Applications (1)

Application Number Title Priority Date Filing Date
YU2634/73A YU39914B (en) 1972-10-16 1973-10-08 Process for obtaining 1-(3-(4-m-chlorophenyl-1-piperazinyl)-propyl)3,4-diethyl-delta2-1,24-triazoline-5-one

Country Status (19)

Country Link
US (1) US3857845A (xx)
JP (1) JPS5550948B2 (xx)
AR (1) AR204086A1 (xx)
AT (1) AT336021B (xx)
BE (1) BE806146A (xx)
CA (1) CA1013746A (xx)
CH (1) CH589643A5 (xx)
DE (1) DE2351739C3 (xx)
DK (1) DK141750B (xx)
ES (1) ES419687A1 (xx)
FI (1) FI58495C (xx)
FR (1) FR2202702B1 (xx)
GB (1) GB1438337A (xx)
IT (1) IT1052119B (xx)
KE (1) KE2823A (xx)
NL (1) NL184782C (xx)
NO (1) NO138565C (xx)
SE (1) SE390819B (xx)
YU (1) YU39914B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1047702B (it) * 1975-07-24 1980-10-20 Acraf Nuova sintesi degli psicofarmaci denominati trazodone ed eteroperidone
US4162318A (en) * 1976-05-05 1979-07-24 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Use of trazodone and etoperidone in Parkinsonism and in other extrapyramidal syndromes characterized by tremors
IT1073639B (it) * 1976-05-05 1985-04-17 Acraf Impiego del trazodone e etoperidone nel morbo di parikinson ed in altre sindromi extrapiramidali caratterizzate da tremori
US4465683A (en) * 1979-09-14 1984-08-14 Mead Johnson & Company Anti-psychotic agents
US4254124A (en) * 1979-09-24 1981-03-03 Mead Johnson & Company Antidepressant agent
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives
US4386091A (en) * 1982-02-24 1983-05-31 Mead Johnson & Company 2-Phenoxyalkyl-1,2,4-triazol-3-one antidepressants
US4575555A (en) * 1983-06-29 1986-03-11 Mead Johnson & Company 4-(3-Chlorophenyl)-1,2,3,6-tetrahydropyridine derivative
US4613600A (en) * 1983-09-30 1986-09-23 Mead Johnson & Company Antidepressant 1,2,4-triazolone compounds
US4784998A (en) * 1987-04-06 1988-11-15 Bristol-Myers Company 1,3,4-oxadiazole pyschotropic compounds
US4931445A (en) * 1988-10-06 1990-06-05 Irwin Goldstein Agents for treatment of male impotence
US5140036A (en) * 1990-09-19 1992-08-18 G. D. Searle & Co. 1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
US5229406A (en) * 1990-09-19 1993-07-20 G. D. Searle & Co. 1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
US5087634A (en) * 1990-10-31 1992-02-11 G. D. Searle & Co. N-substituted imidazol-2-one compounds for treatment of circulatory disorders
US5238952A (en) * 1990-10-31 1993-08-24 G. D. Searle & Co. N-substituted imidazol-2-one compounds for treatment of circulatory disorders
US5196537A (en) * 1991-03-21 1993-03-23 G. D. Searle & Co. 5-apylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
US5164403A (en) * 1991-04-05 1992-11-17 G. D. Searle & Co. N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders
IT1256387B (it) * 1992-11-13 1995-12-04 Acraf Procedimento per preparare triazoloni
CA2182241C (en) * 1996-07-29 2002-09-17 Bo Lei Methods for the manufacture of nefazodone
ES2152860B1 (es) * 1998-10-23 2001-08-16 Finaf 92 Sa Forma cristalina de la nefazodona y procedimiento para su preparacion.
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors

Also Published As

Publication number Publication date
JPS4993381A (xx) 1974-09-05
DE2351739A1 (de) 1974-04-18
NO138565C (no) 1978-09-27
JPS5550948B2 (xx) 1980-12-20
NL184782C (nl) 1989-11-01
NL184782B (nl) 1989-06-01
FR2202702B1 (xx) 1976-07-02
GB1438337A (xx) 1976-06-03
AT336021B (de) 1977-04-12
NL7314204A (xx) 1974-04-18
SE390819B (sv) 1977-01-24
ATA871173A (de) 1976-08-15
DE2351739C3 (de) 1980-09-04
IT1052119B (it) 1981-06-20
BE806146A (fr) 1974-02-15
DK141750B (da) 1980-06-09
FR2202702A1 (xx) 1974-05-10
CH589643A5 (xx) 1977-07-15
CA1013746A (en) 1977-07-12
FI58495B (fi) 1980-10-31
NO138565B (no) 1978-06-19
AR204086A1 (es) 1975-11-20
YU263473A (en) 1983-02-28
ES419687A1 (es) 1976-10-16
DE2351739B2 (de) 1980-01-10
US3857845A (en) 1974-12-31
FI58495C (fi) 1981-02-10
KE2823A (en) 1978-03-31
DK141750C (xx) 1980-11-03

Similar Documents

Publication Publication Date Title
YU39914B (en) Process for obtaining 1-(3-(4-m-chlorophenyl-1-piperazinyl)-propyl)3,4-diethyl-delta2-1,24-triazoline-5-one
YU133379A (en) Process for preparing new 1,2,4-triazole derivatives
YU254979A (en) Process for preparing new 3,4-dihydrocarbostyryl-derivatives
YU321279A (en) Process for obtaining substituted 3,4-dimethoxy-beta-phenetylamines
HU173507B (hu) Sposob poluchenija proizvodnykh 11,15-bis-tetragidro-piraniloksi-omega-tetrano-16-fenoksi-prostaglandina
YU34884B (en) Process for preparing 1,2,3-tiadiazole derivatives
YU128373A (en) Process for preparing 6-phenyl-substituted 3-methyl-4-amino-5h-1,2,4-triazine-5-ones
ZA734811B (en) 1-(3-(5,6,7,8-tetrahydronapht-1-yloxy)-propyl)-piperazine derivatives
YU39722B (en) Process for obtaining 0,0-diethyldithio-phoshoryl-methyl-3-chloro-6-benzoxazolone
YU37153B (en) Process for obtaining new 2,4-diaminobenzyl-pyrimidines
YU83474A (en) Process for obtaining 3-(2-quinoxalinyl-methylene)-carbazate-n1,n4-dioxide
YU40969B (en) Process for obtaining new dithiino-(1,4)(2,3-c)-pyrrole derivtives
YU269273A (en) Process for obtaining 2,10-dichloro-12-methyl-12h-dibenzo (d.g.)-(1,3)dioxocines
YU206774A (en) Process for obtaining 3,4-diamino-benzophenones
YU210473A (en) Process for obtaining novel oxo-3-dihydro-2,3-benzoxazine-1,4 derivatives
YU35149B (en) Process for obtaining 15 delta, 16-methylene-4-pregnene
YU229979A (en) Process for obtaining novel 1,4-benzodixane derivatives
YU39721B (en) Process for obtaining 2,6-dinitroanilines
HU170941B (hu) Sposob poluchenija zamehhjonnykh 2-aril-1,2-digidro-ftalazinov
YU63972A (en) Process for obtaining 1-(2,5-dichlorophenoxy)-3-tert-butyl-amino-2-propanols
CS191448B1 (en) Process for preparing 6,7-dihydrobenztrazole
YU40071B (en) Process for obtaining substituted 2-chloro-4-alkylamino-6-cyanoalky-amino-1,2,3-triazines
PH10582A (en) Process for preparing substituted 1,2,4-triazole derivatives
AU465122B2 (en) 1- [3-(5,6,7,8-tetrahydronapth-1-yloxy)-propyl] - piperazine derivatives
YU34690B (en) Process for obtaining novel 1,3-aminoalochol-benzoates